Silfverschiöld, Maria http://orcid.org/0000-0002-2853-3779
Carlwig, Kristin
Jarl, Johan
Greiff, Lennart
Nilsson, Per
Wennerberg, Johan
Zackrisson, Björn
Östensson, Ellinor
Sjövall, Johanna
Funding for this research was provided by:
Cancerfonden (CAN2010/544, CAN2012/668)
Laryngfonden
Lund University
Article History
Received: 9 November 2022
Accepted: 10 February 2023
First Online: 4 March 2023
Declarations
:
: The authors declare no competing interest.
: The RCT study was approved by the regional ethic committee (Etikprövningsmyndigheten) in Umeå, Sweden (07-178M) and registered at ExternalRef removed and the amendment for the cost-effectiveness analysis protocol was approved by the regional ethic committee (Etikprövningsmyndigheten) in Uppsala, Sweden (no: 2019-05768). All the methods in the study were carried out according to relevant guidelines and regulations. Informed consent was obtained from all persons who entered the study.